Efficacy of repeated intravenous injection of peramivir against influenza a (H1N1) 2009 virus infection in immunosuppressed mice

14Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

The efficacy of intravenous peramivir against influenza A (H1N1) 2009 virus infection was evaluated in mice in which the immune system was suppressed by cyclophosphamide (CP) treatment. The mortality rate of the vehicle control group was 100%, and the mice lost 20% of their body weight on average by day 13 postinfection (p.i.). Repeated administration of peramivir (40 mg/kg of body weight once a day, given intravenously for 20 days), starting at 1 h p.i., significantly reduced mortality, body weight loss, viral titers, and cytokine production in infected mice compared with results for administration of vehicle (P<0.01). In addition, repeated administration of peramivir, starting at 24 h, 48 h, or 72 h p.i., also resulted in increases in survival rates and reduction of viral titers in the lungs (P<0.01). The mean days to death (MDD) of the vehicle group was 14.5 days, while in the groups treated with peramivir starting at 24 h, 48 h, and 72 h p.i., the MDDs were>23.0, 20.9, and 21.8 days, respectively. In comparison, repeated administration of oseltamivir phosphate (5 mg/kg twice a day, given orally for 20 days), starting at 24 h, 48 h, and 72 h p.i., also significantly prevented body weight loss, whereas no significant differences in mortality rates and viral titers in the lungs were observed compared with results for the vehicle group. These data indicated that repeated administration of peramivir was effective in promoting the survival and reducing virus replication in immunosuppressed mice infected with influenza A (H1N1) 2009 virus. Copyright © 2013, American Society for Microbiology. All Rights Reserved.

References Powered by Scopus

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

947Citations
N/AReaders
Get full text

Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: Clinical practice guidelines of the infectious diseases society of America

590Citations
N/AReaders
Get full text

Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice

581Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Peramivir: A novel intravenous neuraminidase inhibitor for treatment of acute influenza infections

67Citations
N/AReaders
Get full text

Hydroxypropyl-β-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen

58Citations
N/AReaders
Get full text

Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8+CD44hi T cells by upregulating IFN-c

42Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kitano, M., Kodama, M., Itoh, Y., Kanazu, T., Kobayashi, M., Yoshida, R., & Sato, A. (2013). Efficacy of repeated intravenous injection of peramivir against influenza a (H1N1) 2009 virus infection in immunosuppressed mice. Antimicrobial Agents and Chemotherapy, 57(5), 2286–2294. https://doi.org/10.1128/AAC.02324-12

Readers' Seniority

Tooltip

Professor / Associate Prof. 4

57%

Researcher 2

29%

PhD / Post grad / Masters / Doc 1

14%

Readers' Discipline

Tooltip

Immunology and Microbiology 4

57%

Agricultural and Biological Sciences 2

29%

Medicine and Dentistry 1

14%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 17

Save time finding and organizing research with Mendeley

Sign up for free